Motor function performance in individuals with RYR1-related myopathies

被引:6
|
作者
Witherspoon, Jessica W. [1 ]
Vuillerot, Carole [2 ,3 ,4 ]
Vasavada, Ruhi P. [5 ]
Waite, Melissa R. [5 ]
Shelton, Monique [1 ]
Chrismer, Irene C. [1 ]
Jain, Minal S. [5 ]
Meilleur, Katherine G. [1 ]
机构
[1] NINR, NIH, Bethesda, MD 20892 USA
[2] Hosp Civils Lyon, Hop Femme Mere Enfant, Escale, Serv Med Phys & Readaptat Pediat, F-69500 Bron, France
[3] Univ Lyon, F-69000 Lyon, France
[4] Univ Lyon 1, F-69100 Villeurbanne, France
[5] NIH, Rehabil Med, Bldg 10, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
disease progression; GFT; MFM; motor function; RYR1; DUCHENNE MUSCULAR-DYSTROPHY; CONGENITAL MYOPATHIES; RYR1;
D O I
10.1002/mus.26491
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction The objective of this study was to obtain a 6-month natural history of motor function performance in individuals with RYR1- related myopathy (RYR1-RM) by using the Motor Function Measure-32 (MFM-32) and graded functional tests (GFT) while facilitating preparation for interventional trials. Methods In total, 34 participants completed the MFM-32 and GFTs at baseline and 6-month visits. Results Motor deficits according to MFM-32 were primarily observed in the standing and transfers domain (D1; mean 71%). Among the GFTs, participants required the most time to ascend/descend stairs (>7.5 s). Functional movement, determined by GFT grades, was strongly correlated with MFM-32 (D1; r >= 0.770, P < 0.001). Motor Function Measure-32 and GFT scores did not reflect any change in performance between baseline and 6-month visits. Discussion The MFM-32 and GFTs detected motor impairment in RYR1-RM, which remained stable over 6 months. Thus, these measures may be suitable for assessing change in motor function in response to therapeutic intervention. Muscle Nerve 60: 80-87, 2019
引用
收藏
页码:80 / 87
页数:8
相关论文
共 50 条
  • [1] Update on RYR1-related myopathies
    Ogasawara, Masashi
    Nishino, Ichizo
    CURRENT OPINION IN NEUROLOGY, 2024, 37 (05) : 504 - 508
  • [2] Oxidative stress and RYR1-related myopathies
    Dowling, J. J.
    McEvoy, A.
    Arbogast, S.
    Kuwada, J. Y.
    Ferreiro, A.
    NEUROMUSCULAR DISORDERS, 2010, 20 (9-10) : 612 - 612
  • [3] Gene therapies for RyR1-related myopathies
    Marty, Isabelle
    Beaufils, Mathilde
    Faure, Julien
    Rendu, John
    CURRENT OPINION IN PHARMACOLOGY, 2023, 68
  • [4] Gene editing for RYR1-related myopathies
    Dulaurier, R. Reynaud
    Ricci, E.
    Risson, V.
    Belotti, E.
    Beaufils, M.
    Rendu, J.
    Marty, I.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A303 - A303
  • [5] Antioxidant therapy in RYR1-related myopathies
    Arveson, I.
    Witherspoon, J.
    Drinkard, B.
    Waite, M.
    Razaqyar, M.
    Tounkara, E.
    Elliott, J.
    Shelton, M.
    Jain, M.
    Bonnemann, C.
    Meilleur, K.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S137 - S137
  • [6] Novel Variants in Individuals with RYR1-Related Congenital Myopathies: Genetic, Laboratory, and Clinical Findings
    Todd, Joshua J.
    Razaqyar, Muslima S.
    Witherspoon, Jessica W.
    Lawal, Tokunbor A.
    Mankodi, Ami
    Chrismer, Irene C.
    Allen, Carolyn
    Meyer, Mary D.
    Kuo, Anna
    Shelton, Monique S.
    Amburgey, Kim
    Niyazov, Dmitriy
    Fequiere, Pierre
    Bonnemann, Carsten G.
    Dowling, James J.
    Meilleur, Katherine G.
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [7] Episodic RYR1-Related Crisis: Part of the Evolving Spectrum of RYR1-Related Myopathies and Malignant Hyperthermia-Like Illnesses
    Dowling, James J.
    Riazi, Sheila
    Litman, Ronald S.
    A & A PRACTICE, 2021, 15 (01)
  • [8] Genotype-phenotype correlations in recessive RYR1-related myopathies
    Amburgey, K.
    Bailey, A.
    Hwang, J. H.
    Tamopolsky, M. A.
    Boennemann, C. G.
    Medne, L.
    Mathews, K. D.
    Collins, J.
    Daube, J. R.
    Wellman, G. P.
    Callaghan, B.
    Vajsar, J.
    Yoon, G.
    Cohn, R.
    Clarke, N. F.
    Dowling, J. J.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 809 - 809
  • [9] Genotype-phenotype correlations in recessive RYR1-related myopathies
    Kimberly Amburgey
    Angela Bailey
    Jean H Hwang
    Mark A Tarnopolsky
    Carsten G Bonnemann
    Livija Medne
    Katherine D Mathews
    James Collins
    Jasper R Daube
    Gregory P Wellman
    Brian Callaghan
    Nigel F Clarke
    James J Dowling
    Orphanet Journal of Rare Diseases, 8
  • [10] Intracellular calcium leak as a therapeutic target for RYR1-related myopathies
    Alexander Kushnir
    Joshua J. Todd
    Jessica W. Witherspoon
    Qi Yuan
    Steven Reiken
    Harvey Lin
    Ross H. Munce
    Benjamin Wajsberg
    Zephan Melville
    Oliver B. Clarke
    Kaylee Wedderburn-Pugh
    Anetta Wronska
    Muslima S. Razaqyar
    Irene C. Chrismer
    Monique O. Shelton
    Ami Mankodi
    Christopher Grunseich
    Mark A. Tarnopolsky
    Kurenai Tanji
    Michio Hirano
    Sheila Riazi
    Natalia Kraeva
    Nicol C. Voermans
    Angela Gruber
    Carolyn Allen
    Katherine G. Meilleur
    Andrew R. Marks
    Acta Neuropathologica, 2020, 139 : 1089 - 1104